Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
Barbara Mora, Hematologist at I.R.C.C.S. Ospedale Maggiore Policlinico, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Happy to share that our collaborative work on the characterization of a recently discovered intronic variant of the erythropoietin gene as a cause of congenital erythrocytosis has been published on the American Journal of Hematology!”
Title: Characterization of a Newly Discovered Non‐Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis
Authors: Barbara Mora, Valentina Bellani, Daniela Pietra, Elena Tagliaferri, Daniele Cattaneo, Oscar Borsani, Alessandra Iurlo, Elisa Fermo, Paola Bianchi, Elisa Rumi, Francesco Passamonti
Read the Full Article on American Journal of Hematology
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiri’s Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership